SE-7552 | MedChemExpress (MCE)
SE-7552, a 2-(difluoromethyl)-1,3,4-oxadiazole (DFMO) derivative, is an orally active, highly selective, non-hydroxamate HDAC6 inhibitor with an IC50 of 33 nM. SE-7552 is greater than 850-fold selectivity versus all other known HDAC isozymes. SE-7552 is capable of blocking multiple myeloma growth in vivo. SE-7552 acts as an anti-obesity agent in diet-induced obese mice[1][2].
| Trivial name | SE-7552 |
| Catalog Number | HY-161305 |
| Research Area | Metabolic Disease; Cancer |
| CAS# | 2243575-79-1 |
| Purity | 99.5% |
| SMILES | FC(F)C(O1)=NN=C1C(C=N2)=CN=C2NC(C)C3=CC=C(F)C=C3 |
| Size | 25 mg |
| Supplier Page | https://www.medchemexpress.com/se-7552.html |